Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
6.64M
-
Shares change
-
-24.4K
-
Total reported value, excl. options
-
$160M
-
Value change
-
-$773K
-
Number of buys
-
14
-
Number of sells
-
-15
-
Price
-
$24.08
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q3 2016
43 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2016.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.64M shares
of 100M outstanding shares and own 6.61% of the company stock.
Largest 10 shareholders include FMR LLC (3.53M shares), Cormorant Asset Management, LLC (498K shares), ORBIMED ADVISORS LLC (350K shares), Tekla Capital Management LLC (310K shares), LAZARD ASSET MANAGEMENT LLC (285K shares), FRANKLIN RESOURCES INC (244K shares), MILLENNIUM MANAGEMENT LLC (182K shares), PERCEPTIVE ADVISORS LLC (180K shares), Clough Capital Partners L P (153K shares), and Artal Group S.A. (150K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.